Dabigatran etexilate mesylate (BIBR 1048MS; oral; 10, 20 and 50 mg/kg for rats and 1, 2.5 and 5 mg/kg for monkeys) has dose- and time-dependent anticoagulant effects and has maximum effects between 30 and 120 min after administration, respectively.
Dabigatran etexilate mesylate maximally and significantly prolongs partial thromboplastin time (aPTT) to 25.2, 38.4 and 78.3 s in 30 min after 10, 20 and 50 mg/kg oral doses, respectively.
Dabigatran etexilate mesylate maximally prolongs the aPTT to 34.3 s, 44.0 s, and 63.0 s, respectively, 2h after 1, 2.5 or 5 mg/kg doses in the monkey.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: |
Male rats (280-350 g) and rhesus monkeys of either sex (3-8 kg) |
Dosage: |
10, 20 and 50 mg/kg for rats and 1, 2.5 and 5 mg/kg for monkeys |
Administration: |
Oral |
Result: |
Had dose- and time-dependent anticoagulant effects.
|